Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Stefan Jaroch"'
Autor:
Markus Berger, Heike Schäcke, Hartmut Rehwinkel, Stefan Jaroch, Ekkehard May, Roland Neuhaus, Thomas M. Zollner, Antje Rottmann
Publikováno v:
Bioorganicmedicinal chemistry letters. 30(16)
We report on the discovery of the new clinical candidate BAY 1003803 as glucocorticoid receptor agonist for the topical treatment of psoriasis or severe atopic dermatitis. In the course of optimizing the amino alcohol series as a highly potent new no
This volume gives an overview of state of the art technologies and future developments in the field of preclinical pharmaceutical research. A balanced mix of experts from academia and industry give insight in selected new developments in the drug dis
Autor:
Lisa Wissler, Stefan Jaroch, Norbert Schmees, Andreas Reichel, Heike Schäcke, Hartmut Rehwinkel, Markus Berger, Karl Edman
Publikováno v:
Bioorganicmedicinal chemistry letters. 27(3)
We report on the discovery of two new lead series for the development of glucocorticoid receptor agonists. Firstly, the discovery of tetrahydronaphthalenes led to metabolically stable and dissociated compounds. Their binding mode to the glucocorticoi
Publikováno v:
Handbook of experimental pharmacology. 232
Publikováno v:
Handbook of Experimental Pharmacology ISBN: 9783319289120
New Approaches to Drug Discovery
New Approaches to Drug Discovery
Preface.- Part 1. Historical View.- Drug discovery in the past and today.Part 2. Target Discovery.- Emerging target families: intractable targets. In vivo target validation especially for biological targets. HR RNAi/High Content analysis.- Part 3. Le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35f414de03e301e28ec0ff7e4140112f
https://doi.org/10.1007/978-3-319-28914-4
https://doi.org/10.1007/978-3-319-28914-4
Autor:
Larry E. Overman, Fay Ng, Sheldon Hiebert, Christopher J. Douglas, Robert Downham, Peter Chua, Neil K. Garg, Joy A. Middleton, Richard T. Matsuoka, Stefan Jaroch, Michael Becker
Publikováno v:
Journal of the American Chemical Society, vol 140, iss 15
Author(s): Becker, Michael H; Chua, Peter; Downham, Robert; Douglas, Christopher J; Garg, Neil K; Hiebert, Sheldon; Jaroch, Stefan; Matsuoka, Richard T; Middleton, Joy A; Ng, Fay W; Overman, Larry E
Autor:
Stefan Jaroch, Yoshimitsu Nakano, Perenlei Enkhbaatar, Collette Jonkam, Matthias Lange, Lillian D. Traber, David N. Herndon, Daniel L. Traber, Jianpu Wang, Atsumori Hamahata
Publikováno v:
Shock. 32:253-257
Smoke inhalation injury is often complicated with pneumonia, which frequently leads to subsequent development of sepsis. Excessive NO has been shown to mediate many sepsis-related pathological responses. In the present study, we used our well-establi
Autor:
Wolf-Dietrich Döcke, Hartmut Rehwinkel, Roland Neuhaus, Werner Skuballa, Khusru Asadullah, U Zügel, Ekkehard May, Stefan Jaroch, Heike Schäcke, Thomas M. Zollner
Publikováno v:
British Journal of Pharmacology. 158:1088-1103
Background and purpose: Glucocorticoids are highly effective in the therapy of inflammatory diseases. Their value, however, is limited by side effects. The discovery of the molecular mechanisms of the glucocorticoid receptor and the recognition that
Autor:
Joy A. Middleton, Robert Downham, Neil K. Garg, Sheldon Hiebert, Michael Becker, Peter Chua, Larry E. Overman, Fay W. Ng, Stefan Jaroch, Richard T. Matsuoka, Christopher J. Douglas
Publikováno v:
Journal of the American Chemical Society. 129:11987-12002
This article describes the details of our synthetic studies toward the complex marine alkaloid sarain A. Various strategies were conceived, setbacks encountered, and solutions developed, ultimately leading to a successful enantioselective total synth
Autor:
Dave Davey, Karen May, Shou-Fu Lu, Ming Wei, Jih-Lie Tseng, Laura Dunning, Gary Phillips, Robert G. Wei, Bin Ye, Stefan Jaroch, James Onuffer, Binglong Chen, Babu Subramanyam
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:1883-1887
The guanylhydrazone of 2-(4-chlorobenzyloxy)-5-bromobenzaldehyde, 1, with an IC50 of 840 nM against the CCR5 receptor was identified using high-throughput screening. Optimization efforts led to the discovery of a novel piperidine series of CCR5 antag